Continentalic acid
Continentalic acid from Aralia continentalis has minimum inhibitory concentrations (MICs) of approximately 8-16 μg/mL against S. aureus, including the Methicillin susceptible Staphylococcus aureus (MSSA) and Methicillin-resistant Staphylococcus aureus (MRSA) standard strains[1].
Product Specifications
CAS Number
19889-23-7
UNSPSC
12352211
Hazard Statement
H400, H410
Target
Bacterial
Type
Natural Products
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/continentalic-acid.html
Purity
99.72
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C[C@]12[C@@](CCC3=C[C@](C=C)(C)CC[C@@]23[H])([H])[C@@](C)(CCC1)C(O)=O
Molecular Formula
C20H30O2
Molecular Weight
302.45
Precautions
H400, H410
References & Citations
Aralia continentalisStaphylococcus aureus
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant SARS-CoV-2 Spike RBD (D405V, Q414A) (His Tag)
P63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/11), 1mg/mL
Haptoglobin (HP) (NM_001126102) Human Over-expression Lysate
4-Hydroxy-1-(3-pyridyl-2,4,5,6-d4)-1-butanone
